E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/26/2006 in the Prospect News Convertibles Daily.

Morgan Stanley to sell 8% Sparqs exchangeable for Genentech

New York, June 26 - Morgan Stanley plans to price an issue of 8% Sparqs (Stock Participation Accreting Redemption Quarterly-pay Securities) mandatorily exchangeable for Genentech, Inc. stock, according to an FWP filing with the Securities and Exchange Commission.

At maturity, investors will receive one share of Genentech stock per Sparq.

The Sparqs will mature on Aug. 20, 2007 and will be callable after Feb. 20, 2007. The yield to call will be set at pricing and is expected to be between 14% and 18%.

Morgan Stanley said it will apply to list the Sparqs on the American Stock Exchange under the symbol "DGK."

Morgan Stanley will manage the offering.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.